1-3 of 3
Kalpna Gupta
Close
Sort by
Journal Articles

End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain

Ann T. Farrell, Julie Panepinto, C. Patrick Carroll, Deepika S. Darbari, Ankit A. Desai, Allison A. King, Robert J. Adams, Tabitha D. Barber, Amanda M. Brandow, Michael R. DeBaun, Manus J. Donahue, Kalpna Gupta, Jane S. Hankins, Michelle Kameka, Fenella J. Kirkham, Harvey Luksenburg, Shirley Miller, Patricia Ann Oneal, David C. Rees, Rosanna Setse, Vivien A. Sheehan, John Strouse, Cheryl L. Stucky, Ellen M. Werner, John C. Wood, William T. Zempsky
Journal: Blood Advances
Blood Adv (2019) 3 (23): 3982–4001.
https://doi.org/10.1182/bloodadvances.2019000882
Published: 2019
Includes: Supplemental data
Journal Articles

Morphine promotes neovascularizing retinopathy in sickle transgeneic mice

Kalpna Gupta, Chunsheng Chen, Gerard A. Lutty, Robert P. Hebbel
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1073–1083.
https://doi.org/10.1182/bloodadvances.2018026898
Published: 2019
Includes: Supplemental data
Journal Articles

Effect of chronic opioid therapy on pain and survival in a humanized mouse model of sickle cell disease

Huy Tran, Varun Sagi, Waogwende Leonce Song-Naba, Ying Wang, Aditya Mittal, Yann Lamarre, Lei Zhang, Kalpna Gupta
Journal: Blood Advances
Blood Adv (2019) 3 (6): 869–873.
https://doi.org/10.1182/bloodadvances.2018024299
Published: 2019
Includes: Supplemental data